{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:05:26Z","timestamp":1774937126833,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.sleep.2015.04.001","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T09:20:10Z","timestamp":1429262410000},"page":"838-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial"],"prefix":"10.1016","volume":"16","author":[{"given":"Neely","family":"Ivgy-May","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Ruwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2015.04.001_bib0010","first-page":"845","article-title":"Sleep neurobiology from a clinical perspective","volume":"34","author":"Espa\u00f1a","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.04.001_bib0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2013.193","article-title":"Insomnia","volume":"309","author":"Buysse","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.sleep.2015.04.001_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2869.1994.tb00112.x","article-title":"Effects of the selective 5-HT1B agonist, CGS 12066B, on sleep\/waking stages and EEG power spectrum in rats","volume":"3","author":"Bjorvatn","year":"1994","journal-title":"J Sleep Res"},{"key":"10.1016\/j.sleep.2015.04.001_bib0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF00439544","article-title":"Functional role of 5-HT2 receptors in the regulation of sleep and wakefulness in the rat","volume":"97","author":"Dugovic","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.sleep.2015.04.001_bib0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(93)90520-R","article-title":"The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat","volume":"249","author":"Ponzoni","year":"1993","journal-title":"Eur J Pharmacol"},{"issue":"Suppl. 4","key":"10.1016\/j.sleep.2015.04.001_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199512004-00004","article-title":"The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission","volume":"10","author":"De Boer","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"issue":"Suppl. 4","key":"10.1016\/j.sleep.2015.04.001_bib0040","doi-asserted-by":"crossref","first-page":"335s","DOI":"10.1016\/0924-9338(96)89051-1","article-title":"Clinical implications of the adrenergenic and serotonergenic receptor binding profile of the new antidepressant mirtazapine","volume":"11","author":"Broekkamp","year":"1996","journal-title":"Eur Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.sleep.2015.04.001_bib0045","doi-asserted-by":"crossref","first-page":"335s","DOI":"10.1016\/0924-9338(96)89052-3","article-title":"Characteristic effects of mirtazapine and other antidepressants on rat sleep EEG","volume":"11","author":"Ruigt","year":"1996","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.sleep.2015.04.001_bib0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/sleep\/25.6.666","article-title":"The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers","volume":"25","author":"Aslan","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.04.001_bib0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-3223(00)00882-9","article-title":"Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study","volume":"48","author":"Winokur","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.sleep.2015.04.001_bib0060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/syn.21532","article-title":"Effects of mirtazapine on sleep disturbance under neuropathic pain-like state","volume":"66","author":"Enomoto","year":"2012","journal-title":"Synapse"},{"key":"10.1016\/j.sleep.2015.04.001_bib0065","first-page":"A224","article-title":"A Phase II randomized, 4-way cross-over, double-blind, placebo-controlled, multicenter dose-finding trial with esmirtazapine in patients with primary insomnia","volume":"35","author":"Ruwe","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.04.001_bib9010","article-title":"Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial","author":"Ivgy-May","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.04.001_bib0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/pop.2009.0028","article-title":"Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings","volume":"13","author":"Bolge","year":"2010","journal-title":"Popul Health Manag"},{"key":"10.1016\/j.sleep.2015.04.001_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10401230500464711","article-title":"Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies","volume":"18","author":"Rosenberg","year":"2006","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.sleep.2015.04.001_bib0085","first-page":"48","article-title":"Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression","volume":"3","author":"Krystal","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.sleep.2015.04.001_bib0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smrv.2012.08.001","article-title":"Review of the histamine system and the clinical effects of H1 antagonists: basis for a new model for understanding the effects of insomnia medications","volume":"17","author":"Krystal","year":"2013","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2015.04.001_bib0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-4328(01)00222-4","article-title":"Modifying effects of histamine on circadian rhythms and neuronal excitability","volume":"124","author":"Tuomisto","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.sleep.2015.04.001_bib0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-010-2149-4","article-title":"Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype","volume":"215","author":"Ramaekers","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.sleep.2015.04.001_bib0105","series-title":"A Phase II randomized, 4-way cross-over, double-blind, placebo-controlled, multicenter dose-finding trial with esmirtazapine in patients with primary insomnia","author":"Ruwe","year":"2012"},{"key":"10.1016\/j.sleep.2015.04.001_bib0110","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1185\/174234304X15174","article-title":"Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia","volume":"20","author":"Zammit","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sleep.2015.04.001_bib0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.sleep.2006.04.008","article-title":"Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia","volume":"7","author":"Roth","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2015.04.001_bib0120","first-page":"1433","article-title":"Efficacy and safety of doxepin 3 and 6\u2009mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia","volume":"34","author":"Krystal","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2015.04.001_bib0125","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1176\/appi.neuropsych.23.1.E7","article-title":"Rapid weight gain during mirtazapine treatment","volume":"23","author":"Chiu","year":"2011","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.sleep.2015.04.001_bib0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0165-0327(98)00224-9","article-title":"Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression","volume":"51","author":"Fawcett","year":"1998","journal-title":"J Affect Disord"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945715006978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945715006978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T13:41:25Z","timestamp":1668778885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945715006978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1389945715006978"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2015.04.001","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2015.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}